| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
DDN is the largest privately held provider of outsourced services to the life-science industry. We have decades of experience in every sector, and a long track record of unparalleled client satisfaction.
Gateway Community Health Center, Inc. is a community health center funded by the U.S. Department of Health and Human Services. The Center is a 501 (c) (3) private, non-profit corporation with a governing board of 15 directors whose responsibility is t...
Reliance Health Care Mgmt., Inc. is a Conway, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.